Src mediates acquired resistance to ALK inhibitor in ALK-rearranged non-small cell lung cancers

被引：0
|
作者：
Yoshida, Ryohei
Okumura, Shunsuke
Sasaki, Takaaki
Osaki, Yoshinobu
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-2121
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2121
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Development of an ALK vaccine to treat ALK-rearranged non-small cell lung cancers
    Blasco, Rafael B.
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [2] Fibroblast growth factor receptor 3 overexpression mediates ALK inhibitor resistance in ALK-rearranged non-small cell lung cancer
    Sakashita, Takuya
    Yanagitani, Noriko
    Koike, Sumie
    Low, Siew-Kee
    Takagi, Satoshi
    Baba, Satoko
    Takeuchi, Kengo
    Nishio, Makoto
    Fujita, Naoya
    Katayama, Ryohei
    CANCER SCIENCE, 2022, 113 (11) : 3888 - 3900
  • [3] New Strategies for Treatment of ALK-Rearranged Non-Small Cell Lung Cancers
    Sasaki, Takaaki
    Jaenne, Pasi A.
    CLINICAL CANCER RESEARCH, 2011, 17 (23) : 7213 - 7218
  • [4] Monomerization of ALK Fusion Proteins as a Therapeutic Strategy in ALK-Rearranged Non-small Cell Lung Cancers
    Hirai, Noriko
    Sasaki, Takaaki
    Okumura, Shunsuke
    Minami, Yoshinori
    Chiba, Shinichi
    Ohsaki, Yoshinobu
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [5] Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers
    Katayama, Ryohei
    Shaw, Alice T.
    Khan, Tahsin M.
    Mino-Kenudson, Mari
    Solomon, Benjamin J.
    Halmos, Balazs
    Jessop, Nicholas A.
    Wain, John C.
    Yeo, Alan Tien
    Benes, Cyril
    Drew, Lisa
    Saeh, Jamal Carlos
    Crosby, Katherine
    Sequist, Lecia V.
    Iafrate, A. John
    Engelman, Jeffrey A.
    SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (120)
  • [6] Mechanisms of acquired crizotinib resistance in ALK-rearranged lung cancers
    Katayama, Ryohei
    Shaw, Alice T.
    Khan, Tahsin M.
    Mino-Kenudson, Mari
    Iafrate, Anthony J.
    Engelman, Jeffrey A.
    CANCER RESEARCH, 2012, 72
  • [7] TARGETING ALK-REARRANGED NON-SMALL CELL LUNG CARCINOMA
    Iafrate, J.
    Kwak, E.
    Bang, Y.
    Solomon, B.
    Shaw, A.
    Camidge, D. R.
    Ou, S. H.
    Maki, R.
    Salgia, R.
    Clark, J.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S20 - S20
  • [8] Overcoming crizotinib resistance in ALK-rearranged non-small cell lung cancer
    Qi, Xiaolong
    Ma, Wang
    Li, Sen
    Zhou, Caicun
    LUNG CANCER, 2014, 85 (02) : 335 - 336
  • [9] Ceritinib-a second-generation ALK inhibitor overcoming resistance in ALK-rearranged non-small cell lung cancer
    Rothschild, Sacha I.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2014, 3 (06) : 379 - 381
  • [10] Mechanisms of Acquired Resistance to the ALK Inhibitor Lorlatinib in ALK-Rearranged NSCLC Cell Lines
    Madsen, A.
    Jakobsen, K.
    Demuth, C.
    Sorensen, B.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2255 - S2255
12345